Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) have proven efficacy and safety in randomized clinical trials and observational real-life studies
Improvements in cardiometabolic markers, such as blood pressure, cholesterol levels, and fasting blood sugar levels, are also likely to reverse when discontinuing a GLP-1
Not everyone who experiences a Chronic Illness will have MCAS, but it is estimated that 50% of people with Chronic Illness have MCAS or histamine intolerance and therefore it can be common territory for those with chronic fatigue, post-viral fatigue, long covid or other energy limiting illness
In world practice, enzymes such as alpha-lipoic acid and L-carnitine are used for this purpose
Why Researchers Combine CJC-1295 and Ipamorelin The CJC-1295 + Ipamorelin combination pairs a synthetic GHRH analog with a selective GHSR (growth hormone secretagogue receptor) agonist, targeting the two distinct receptor pathways that regulate pituitary growth hormone release